Get the Stockscreener App
368.69
0.38%
1.79
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $368.69, with a volume of 566.11K.
It is up +0.38% in the last 24 hours and up +4.86% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$366.90
Open:
$366.24
24h Volume:
566.11K
Relative Volume:
0.54
Market Cap:
$140.25B
Revenue:
$21.97B
Net Income/Loss:
$3.59B
P/E Ratio:
54.70
EPS:
6.74
Net Cash Flow:
$3.21B
1W Performance:
+2.58%
1M Performance:
+4.86%
6M Performance:
+12.13%
1Y Performance:
+33.33%
1-Day Range:
$363.05
$369.35
1-Week Range:
$355.56
$373.73
52-Week Range:
$266.93
$374.63
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Robeco Institutional Asset Management B.V. Decreases Stock Holdings in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker's SWOT analysis: medical device giant's stock shows robust growth - Investing.com
Global Guidewires Market Poised for Significant Growth: Surge in Minimally Invasive Procedures and Technological Advancements Drive Market toward USD 6,885.7 million by 2034 | FMI - GlobeNewswire Inc.
Stryker Co. (NYSE:SYK) Shares Acquired by QRG Capital Management Inc. - MarketBeat
Stryker Corporation: How Are They Bolstering Growth Through Targeted Acquisitions?Major Drivers - Smartkarma
Capital Advisors Inc. OK Boosts Stock Holdings in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker Corporation (NYSE:SYK) Q3 2024 Earnings Call Transcript - Insider Monkey
What is Roth Capital's Forecast for Stryker FY2024 Earnings? - MarketBeat
Stryker price target raised to $400 from $360 at Canaccord - Yahoo Finance
Assenagon Asset Management S.A. Has $3.72 Million Stock Position in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Earnings: Stellar Quarterly Results Underscore Stryker's Strong Innovation and Operations - Morningstar
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus.com
The Top 10 Donors by Party in the Swing State of Michigan - U.S. News & World Report
Earnings call: Stryker reports robust Q3 growth, raises 2024 outlook - Investing.com
Stryker's Strong Q3 Results and Future Outlook Amid Premium Valu - GuruFocus.com
Stryker Stock Gains on Q3 Earnings Beat & Raised Guidance - Yahoo Finance
Stryker shares target up as Piper Sandler notes strong balance sheet for M&A plans - Investing.com
Piper Sandler Reiterates "Overweight" Rating for Stryker (NYSE:SYK) - MarketBeat
Stryker, Zimmer outline different M&A strategies - MedTech Dive
Truist raises Stryker stock target, maintains Hold rating on revenue growth - Investing.com
Stryker (NYSE:SYK) Announces Earnings Results - MarketBeat
Stryker Corp (SYK): Among UBS’ Top Tech Based Disruptive Stocks For 2030 - MSN
Stryker's Strengths in Innovation and Operations Shine - Morningstar
Stryker price target raised to $405 from $381 at Wells Fargo - TipRanks
Stryker price target raised to $405 from $378 at Baird - TipRanks
Stryker stock gains target boost amid high MedTech growth outlook - Investing.com
Robert W. Baird Raises Stryker (NYSE:SYK) Price Target to $405.00 - MarketBeat
Stryker price target raised to $394 from $383 at BTIG - TipRanks
Analyst Expectations For Stryker's Future - Benzinga
Stryker’s net sales increase 11.9% to USD 5.5B in Q3 2024 - Medical Buyer
BTIG raises Stryker shares target—can the premium valuation keep up? - Investing.com
Stryker Co. (NYSE:SYK) Stock Holdings Trimmed by abrdn plc - MarketBeat
Stryker Corp Reports Strong Third Quarter 2024 Growth - TipRanks
Stryker: Q3 Earnings Snapshot - The Advocate
Stryker Corp (SYK) Q3 2024 Earnings Call Highlights: Strong Organic Sales Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q3 2024 Earnings Call Highlights: Strong Orga - GuruFocus.com
Stryker posts Street-beating Q3, raises low end of guidance - Mass Device
Stryker (NYSE:SYK) Updates FY 2024 Earnings Guidance - MarketBeat
Stryker raises annual profit forecast on robust demand for medical, surgical devices - ETHealthWorld
Stryker Corp's Improved Forecast Drives Stock Higher - Finimize
Stryker Corp (SYK) Q3 Earnings: EPS of $2.16 Beats Estimates, Revenue Surges to $5.5 Billion - GuruFocus.com
Here's What Key Metrics Tell Us About Stryker (SYK) Q3 Earnings - Yahoo Finance
Stryker (SYK) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Stryker Raises FY24 Adjusted Guidance on Strong 3Q Results - Marketscreener.com
Stryker stock jumps as Q3 earnings, outlook top estimates - Investing.com
Stryker earnings beat by $0.10, revenue topped estimates - Investing.com
Stryker stock jumps as Q3 earnings, outlook top estimates By Investing.com - Investing.com UK
Stryker Seeks M&A - Marketscreener.com
Stryker reports third quarter 2024 operating results - The Manila Times
STRYKER : REPORTS THIRD QUARTER 2024 OPERATING RESULTS Form 8 K - Marketscreener.com
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):